Quadrant Private Wealth Management LLC Sells 1,505 Shares of GE HealthCare Technologies Inc. $GEHC

Quadrant Private Wealth Management LLC reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 29.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,540 shares of the company’s stock after selling 1,505 shares during the quarter. Quadrant Private Wealth Management LLC’s holdings in GE HealthCare Technologies were worth $262,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the business. N.E.W. Advisory Services LLC purchased a new stake in shares of GE HealthCare Technologies in the first quarter worth approximately $25,000. Bogart Wealth LLC grew its position in GE HealthCare Technologies by 260.0% in the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock valued at $28,000 after acquiring an additional 247 shares during the last quarter. Gladwyn Financial Advisors Inc. purchased a new stake in GE HealthCare Technologies in the second quarter worth $34,000. Game Plan Financial Advisors LLC lifted its position in shares of GE HealthCare Technologies by 295.3% during the second quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock worth $37,000 after purchasing an additional 375 shares during the last quarter. Finally, Zions Bancorporation National Association UT bought a new stake in shares of GE HealthCare Technologies during the first quarter worth $42,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC opened at $73.05 on Friday. The firm has a 50 day moving average of $75.12 and a 200 day moving average of $73.50. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. The company has a market capitalization of $33.28 billion, a price-to-earnings ratio of 15.09, a price-to-earnings-growth ratio of 2.75 and a beta of 1.13. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.02. The business had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The business’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the firm earned $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio is presently 2.89%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on GEHC. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Tuesday, October 14th. Barclays began coverage on shares of GE HealthCare Technologies in a research report on Monday, October 13th. They set an “equal weight” rating and a $86.00 target price on the stock. BTIG Research set a $87.00 price objective on GE HealthCare Technologies in a research note on Wednesday, October 29th. Evercore ISI lifted their target price on GE HealthCare Technologies from $88.00 to $92.00 and gave the company an “outperform” rating in a research report on Thursday, October 30th. Finally, Zacks Research downgraded GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Six investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $86.10.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.